Fair Value Measurements - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | 12 Months Ended | ||
---|---|---|---|---|---|
Sep. 30, 2019 |
Sep. 30, 2018 |
Sep. 30, 2019 |
Sep. 30, 2018 |
Dec. 31, 2018 |
|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
Gain (loss) due to change in value of note payable | $ (5) | $ 13 | $ (12) | $ (68) | |
VenturEast | BioServe | |||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
Number of shares associated with notes payable (in shares) | 2,809 | 2,809 | |||
Gain (loss) due to change in value of note payable | 5 | (13) | $ 12 | 68 | |
2016 Offering | Significant Unobservable Inputs (Level 3) | Fair Value Measurements, Recurring | |||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||||
Gain on derivative due to change in stock price | $ 34 | $ 12 | $ 233 | $ 2,858 |
X | ||||||||||
- Definition Business Combination, Consideration Transferred, Notes Payable in Shares No definition available.
|
X | ||||||||||
- Definition Gain (Loss) On Derivatives Instruments From Stock Price Change No definition available.
|
X | ||||||||||
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|